BIOPLAN: software for the biological evaluation of. Radiotherapy treatment plans.

Distributions of absorbed dose do not provide information on the biological response of tissues (either tumor or organs at risk [OAR]) to irradiation. BIOPLAN (BiOlogical evaluation of PLANs) has been conceived and developed as a PC-based user-friendly software that allows the user to evaluate a treatment plan from the (more objective) point of view of the biological response of the irradiated tissues, and at the same time, provides flexibility in the use of models and parameters. It requires information on dose-volume histograms (DVHs) and can accept a number of different formats (including DVH files from commercial treatment planning systems). BIOPLAN provides a variety of tools, such as tumor control probability (TCP) calculations (using the Poisson model), normal tissue complication probability (NTCP) calculations (using either the Lyman-Kutcher-Burman or the relative seriality models), the ATCP method, DVH subtraction, plots of NTCP/TCP as a function of prescription dose, tumor and OAR dose statistics, equivalent uniform dose (EUD), individualized dose prescription, and parametric sensitivity analysis of the TCP/NTCP models employed.

[1]  G. Gagliardi,et al.  Modeling heart and lung complication data in radiation therapy of the breast , 2000 .

[2]  M. Goitein,et al.  Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.

[3]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[4]  R Oyen,et al.  Cell kinetic measurements in prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[5]  S Webb,et al.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.

[6]  A Brahme,et al.  Tumour and normal tissue responses to fractionated non-uniform dose delivery. , 1992, International journal of radiation biology.

[7]  A. Niemierko,et al.  Modeling of normal tissue response to radiation: the critical volume model. , 1993, International journal of radiation oncology, biology, physics.

[8]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[9]  J F Fowler,et al.  A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma. , 1995, International journal of radiation oncology, biology, physics.

[10]  D P Dearnaley,et al.  Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data. , 2001, International journal of radiation oncology, biology, physics.

[11]  J. Fowler The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[12]  H. Withers,et al.  Treatment volume and tissue tolerance. , 1988, International journal of radiation oncology, biology, physics.

[13]  A. Niemierko Reporting and analyzing dose distributions: a concept of equivalent uniform dose. , 1997, Medical physics.

[14]  M Goitein,et al.  Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  A Ottolenghi,et al.  Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model. , 1996, The British journal of radiology.

[16]  A. Nahum,et al.  The delta-TCP concept: a clinically useful measure of tumor control probability. , 1999, International journal of radiation oncology, biology, physics.

[17]  J H Hendry,et al.  The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  A. Barrett,et al.  The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  M Goitein,et al.  Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  C. Perez,et al.  Principles and Practice of Radiation Oncology , 1987 .

[21]  A. Niemierko,et al.  Optimization of 3D radiation therapy with both physical and biological end points and constraints. , 1992, International journal of radiation oncology, biology, physics.